| 摘要 |
The present invention is directed to, inter alia, methods of treating or ameliorating an effect of a polycystic disease. This method include administering to a patient in need thereof an amount of a modulator of a histone deacetylase (HDAC) pathway, which is sufficient to treat or ameliorate an effect of a polycystic disease, particularly a polycystic kidney disease. |
